Promore Pharma is granted a patent for LL-37 in Japan


STOCKHOLM, 27 August 2019 – Promore Pharma AB, a Swedish biopharmaceutical developer of therapeutic peptides, today announced that the company was granted a patent in Japan for the usage of LL-37 for treating chronic wounds.

Läs hela meddelandet på Promore Pharmas hemsida.

Läs mer..

Västra Hamnen Corporate Finance AB | Jungmansgatan 12 | 211 11 Malmö | 040-200 250 |